US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Cochlear (PK) (CHEOF) 銘柄情報

Cochlear (PK) (CHEOF)

76.33

0.00

(0.00%)

終了 6月21日 5:00AM

Cochlear (PK) (CHEOF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

76.33

( - )

買値

66.10

売値

6,089.85

出来高

-

0.00 日の範囲 0.00

64.3944 52 週間の範囲 207.71

時価総額

前日終値

76.33

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 605,160

発行済株式数

65,398,681

配当利回り

4.3 (4.30%)

PER

19.69

1 株当たり利益 (EPS)

5.27

歳入

2.34B

純利益

345.3M

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal ... Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.cochlear.com

本社

Sydney, Australia

設立

1981

Cochlear (PK) is listed in the Healthcare sector of the その他OTC with ticker CHEOF. The last closing price for Cochlear (PK) was US$76.33. Over the last year, Cochlear (PK) shares have traded in a share price range of US$ 64.3944 to US$ 207.71.

Cochlear (PK) currently has 65,398,681 shares in issue. The market capitalisation of Cochlear (PK) is US$4.99 billion. Cochlear (PK) has a price to earnings ratio (PE ratio) of 19.69.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	2.78	3.77974167233	73.55	76.33	72.911	548	73.55235484	CS
4	6.925376	9.97826311976	69.404624	76.33	68.045	3854	72.56680978	CS
12	-38.65	-33.6145416594	114.98	129.23	64.3944	1920	72.36780888	CS
26	-92.34	-54.7459536373	168.67	197.11	64.3944	1314	79.63377153	CS
52	-114.46873	-59.9944926258	190.79873	207.71	64.3944	723	84.01361585	CS
156	-87.165	-53.3135569895	163.495	237.38	64.3944	372	117.43121735	CS
260	-107.88	-58.563595896	184.21	237.38	64.3944	310	127.9356331	CS

CHEOF - Frequently Asked Questions (FAQ)

What is the current Cochlear (PK) share price?

The current share price of Cochlear (PK) is US$ 76.33

How many Cochlear (PK) shares are in issue?

Cochlear (PK) has 65,398,681 shares in issue

What is the market cap of Cochlear (PK)?

The market capitalisation of Cochlear (PK) is USD 4.99B

What is the 1 year trading range for Cochlear (PK) share price?

Cochlear (PK) has traded in the range of US$ 64.3944 to US$ 207.71 during the past year

What is the PE ratio of Cochlear (PK)?

The price to earnings ratio of Cochlear (PK) is 19.69

What is the cash to sales ratio of Cochlear (PK)?

The cash to sales ratio of Cochlear (PK) is 2.9

What is the registered address of Cochlear (PK)?

The registered address for Cochlear (PK) is 1 University Avenue, Sydney, New South Wales, 2109

What is the Cochlear (PK) website address?

The website address for Cochlear (PK) is www.cochlear.com

Which industry sector does Cochlear (PK) operate in?

Cochlear (PK) operates in the Medical Equipment & Supplies sector

R1250gs

R1250gs 2秒前

My target is to own 1000 Sol's and put them into a self-custody crypto wallet for a long term investment. I think Sol has a tremendous potential to grow big...

Mister4

Mister4 6分前

Yes, the NWS was certainly illegal. That being said, in my opinion, the terms of the conservatorship are a major Takings violation. Who gives a loan that when paid off the lender owns 95% of the collateral for the loan? The warrants alone represent 80% of the outstanding stock. Who besides the gover

CanItBThisEZ2Make

CanItBThisEZ2Make 9分前

BEST SELLERS RANK (BSR) IS 356 45 Estimated Sold on Amazon Since APRIL 1 - 2ND Quarter 2026
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value D

SeaBlue

SeaBlue 16分前

Rules for thee and not for me - that is what is going on with the Trumper family AND CONgress.

I'll watch the Tom Lee video in a while - gotta head out on some errands.

I am looking forward to what is hopefully good news from the federal/provincial govt. by the end of

CaptBeer

CaptBeer 16分前

REDUCE-IT CKM: In REDUCE-IT secondary prevention patients, the CKM syndrome was associated with incremental CVD risk compared with MetS without diabetes and normal renal function. IPE treatment further reduced CVD risk in patients with CKM, thereby supporting a role for this therapy in affected pati

toohot

toohot 18分前

Conductor TOOHOT checking in—thanks for your patience during the brief pause.
The BIEL Train Bound for Glory resumes boarding this Monday.
Entry prices remain low—for now.
All aboard to those joining the ride. 🚂
$BIEL

BUY $BI

Implanting

Implanting 18分前

Here's the interview. Frank G. is one of my favorites.

https://www.youtube.com/watch?v=bNuljOP4Ric

Investor2014

Investor2014 18分前

Don't forget the 58 amazing scientists signing away their reputation on the peer reviewed paper and the entire Scientific Advisory Board that must have been implicit too.

The alternative is simply a poorly run biotech with a drug that may not work well enough to gain approval and a bu

DJknows

DJknows 23分前

Of course I agree with you ... there's no way IQM Quantum is not familiar with Perkinamine and who knows to what extent they're using it.

Dr. Ciesla is joing an apparently impressive team at IQM, which has four co-founders according to its website:

https://iqm.tech/pres

learningcurve2020

learningcurve2020 25分前

“Safe” yet no pediatric trials for the most vulnerable? Safe is good but can also be a red flag that the drug/cell therapy is not active enough. My guess is skip right over DCVAX to genetically modified DC’s. 🤷‍♀️. Hopefully the CDMO is preparing??

Sunnybank

Sunnybank 26分前

Mates-Have a wonderful Father's Day with parents and/or children. Fair Winds to All!

Monksdream

Monksdream 26分前

GOOG!, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/pyifrIMG_2248.png

Monksdream

Monksdream 26分前

GOOG!, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/pyifrIMG_2248.png

SeaBlue

SeaBlue 28分前

Video with Frank G. Just watch from about 37:20 to 39:10. This is good news, particularly for Duparquet, but also for Springpole. Improved permitting times will help FF a lot. I am also glad because the money generated will be good for Canada.
https://www.youtube.com/watch?v=bNuljOP4Ri

learningcurve2020

learningcurve2020 29分前

T cell and Genetically modified dendritic cells.

Lacey1

Lacey1 29分前

What did it cost to produce that report? And how long to write it up. Looks like a pure hit piece. Effective in driving the price to all time lows. Where do we go from here. We need a partner. We need to submit to the FDA for NDA this year. Is that still a possibility? With Kennedy at the

ScottishTexan

ScottishTexan 33分前

I have a very different take. They know that 400m shares is enough to pay themselves and seems like good news. They know that the market is disappointed that it’s not sandbox. The 20000-1 split was brutal but at least we are able to salvage something from it . The market makers have to be much more

Soog

Well ok; I'll go along with this if you feel it's good. It must have been planned all the time.

GetSeriousOK

GetSeriousOK 36分前

I don't know what happened, and it certainly looks like Mayer is no longer CEO, but I think you're lying when you say that "Zubcevik stated Mayer is no longer with the company."

Did you just have coffee with her? LOL

I don't think Mayer left the company. I don't know wh

Implanting

Implanting 39分前

Trump would have to make it look like whatever problems Stategy/Saylor have are related to them and NOT to Bitcoin, so that's the trick. Trump wants to pick it up cheap, but not make it look like Bitcoin has no value or is a worthless ponzi, so it would have to be a Strategy related issue, not a Bit

eliminate

eliminate 39分前

Apparently
the FBI has captured the 2 top fraudsters on their list but so far haven’t captured Madoff or Ivan Bolskys buddies on any of the exchanges Guess we will have to see who else is playing in the pool beside the monument

straightword

straightword 40分前

Easy cop out. You say this because you know with certainty that you will NEVER be able to meet it!! So much for those s-called patents worth "billions and billons ongoing" huh? The fact is that they aren't!!

Genz2

I think Steven Sprague or Bill Solms who worked for Microsoft should call them up and say “Look guys and gals, Wave could do so much to bring Microsoft to new heights and dominate cybersecurity with BETTER SECURITY!!!” With the Trusted Computing Group behind them, and with Wave’s and Microsoft’s ma

rosemountbomber

rosemountbomber 43分前

Thanks for posting. Remarkable stuff.

mdb1

The 20,000 millionaire employee at SpaceX love the "baa" and are thankful for the sheep followers. Only in America .. go Elon.

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。